| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |